Neil Morris was diagnosed with acute lymphoblastic leukaemia in November 2023 after experiencing what he thought was ...
Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...
A SPORTY nine-year-old described as the “epitome of health” received a shock diagnosis after suffering a "massive" nosebleed. Sammy Balmforth, from Biddulph, Staffordshire, was “born with a ...
Germany: A recent study published in the Leukemia Journal suggests that higher maternal body mass index (BMI) during ...
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in ...
Efforts to cure BCR::ABL1 B cell acute lymphoblastic leukemia (Ph+ ALL) solely through inhibition of ABL1 kinase activity have thus far been insufficient despite the availability of tyrosine kinase ...
It occurs when your child’s bone marrow produces too much of a type of white blood cell called a lymphoblast. The “acute” in ALL means it usually spreads quickly if not treated. AML is the second most ...